Mycenax Biotech Inc.

Mycenax Biotech Inc.verified

4726.TWO

Price:

$33.25

Market Cap:

$6.89B

Mycenax Biotech Inc. develops and manufactures biopharmaceutical products from mammalian and microbial cell lines in Taiwan, Europe, Asia, and the United States. The company develops monoclonal antibodies, bi-specific antibodies, fc-fusion proteins, recombinant proteins, peptides, protein conjugates (non-toxin), antibody-cell conjugates, enzymes, antigen-binding fragments (Fab), and single-chain variable fragments (ScFv), as well as plasmids and DNA vaccines. It also provides process development solutions, including development of production cell lines, upstream and downstream process development, process scale-up, formulation development, and analytical methods; in-house analytical services...[Read more]

Industry

Biotechnology

IPO Date

2012-06-20

Stock Exchange

TWO

Ticker

4726.TWO

The PE Ratio as of November 2025 (TTM) for Mycenax Biotech Inc. (4726.TWO) is -14.33

According to Mycenax Biotech Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -14.33. This represents a change of -22.74% compared to the average of -18.55 of the last 4 quarters.

Mycenax Biotech Inc. (4726.TWO) Historical PE Ratio (quarterly & annually)

How has 4726.TWO PE Ratio performed in the past?

The mean historical PE Ratio of Mycenax Biotech Inc. over the last ten years is 2.29. The current -14.33 PE Ratio has changed -62586.12% with respect to the historical average. Over the past ten years (40 quarters), 4726.TWO's PE Ratio was at its highest in in the March 2023 quarter at -8.38. The PE Ratio was at its lowest in in the June 2024 quarter at -31.12.

Quarterly (TTM)
Annual

Average

2.29

Median

-13.53

Minimum

-62.63

Maximum

133.17

Mycenax Biotech Inc. (4726.TWO) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Mycenax Biotech Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 80.77%

Maximum Annual PE Ratio = 133.17

Minimum Annual Increase = -1094.50%

Minimum Annual PE Ratio = -62.63

Quarterly (TTM)
Annual
YearPE RatioChange
2024-19.1480.77%
2023-10.59-22.54%
2022-13.67-78.18%
2021-62.63-147.03%
2020133.17-1094.50%

Mycenax Biotech Inc. (4726.TWO) Average PE Ratio

How has 4726.TWO PE Ratio performed in the past?

The current PE Ratio of Mycenax Biotech Inc. (4726.TWO) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

-14.46

5-year avg

5.43

10-year avg

2.29

Mycenax Biotech Inc. (4726.TWO) PE Ratio vs. Peers

How is 4726.TWO’s PE Ratio compared to its peers?

Mycenax Biotech Inc.’s PE Ratio is greater than CHO Pharma, Inc. (-27.92), greater than Pharmosa Biopharm Inc. (-22.60), greater than TaiGen Biopharmaceuticals Holdings Limited (-28.24), less than OBI Pharma, Inc. (-2.72), less than Sinphar Pharmaceutical Co.,Ltd. (17.86), greater than Adimmune Corporation (-39.94), less than Acepodia, Inc. (-13.46), less than AnnJi (-13.24), greater than Formosa Pharmaceuticals, Inc. (-68.32), less than Panion & Bf Biotech Inc. (46.06),

Build a custom stock screener for Mycenax Biotech Inc. (4726.TWO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Mycenax Biotech Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Mycenax Biotech Inc. (4726.TWO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Mycenax Biotech Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Mycenax Biotech Inc.'s PE Ratio?

How is the PE Ratio calculated for Mycenax Biotech Inc. (4726.TWO)?

What is the highest PE Ratio for Mycenax Biotech Inc. (4726.TWO)?

What is the 3-year average PE Ratio for Mycenax Biotech Inc. (4726.TWO)?

What is the 5-year average PE Ratio for Mycenax Biotech Inc. (4726.TWO)?

How does the current PE Ratio for Mycenax Biotech Inc. (4726.TWO) compare to its historical average?